INS and type 2 diabetes mellitus: This is reflected in the International Consensus guidelines for the use of CGMs which advise that this technology ‘should be considered, along with HbA1c, to assess glycaemia in patients with insulin-treated T2D, especially if experiencing problematic hypoglycaemia’27, 44.